MYX vs NXN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

NXN

NEXSEN LTD FPO [NXN]

51MEDIUM

Score Breakdown

MYX NXN
Technical
51
46
Catalyst
53
50
Sentiment
50
50
Fundamental
85
66
Momentum
38
54
Risk Gate
42
42

Key Metrics

MYX Metric NXN
$233.2MMarket Cap$58.1M
291KAvg Volume (20d)197K
+2.5%Short InterestN/A
$6.50052-Week High$0.345
$2.04052-Week Low$0.130
-0.7%Daily Change-6.9%
$2.810Reference Price$0.270
-20.6%ROEN/A
-20.4%Profit MarginN/A

Active Signals

MYX Signals

Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Near 52-week low (19% of range)
CANSLIM I: Institutional ownership (36%)
Deeply negative margins (-20%)

NXN Signals

Took a hit — down 18.2% over the last 5 days
Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Adequate cash runway (8 quarters)
Very high P/S ratio (62.3x)
Piotroski F-Score weak (3/9, low-confidence approx)
Small-cap ($20-100M)
CANSLIM S: Tight float (32%)
CANSLIM I: Institutional ownership (17%)

Ask Scout AI to compare MYX and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

SNT vs TRI →SLD vs TRI →NXN vs TRI →ONE vs SNT →ONE vs SLD →
MYX Full Analysis → NXN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).